Dosing & Uses
AdultPediatric
Not indicated for adults, see Pediatric Dosing & Uses
Respiratory Syncytial Virus Prevention
Pending FDA approval as a single SC injection to prevent respiratory syncytial virus (RSV) in infants, including those born healthy, at term or preterm, or with specific health conditions
Next:
Pharmacology
Mechanism of Action
Recombinant human IgG1 kappa monoclonal antibody that binds the F1 and F2 subunits of the RSV fusion (F) protein at a highly conserved epitope; this binding locks the RSV F protein in the prefusion conformation to block viral entry into the host cell
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
